A detailed history of Charles Schwab Investment Management Inc transactions in Absci Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 697,849 shares of ABSI stock, worth $1.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
697,849
Previous 686,247 1.69%
Holding current value
$1.87 Million
Previous $2.11 Million 26.12%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.97 - $4.49 $34,457 - $52,092
11,602 Added 1.69%
697,849 $2.67 Million
Q2 2024

Aug 12, 2024

BUY
$2.92 - $6.58 $977,744 - $2.2 Million
334,844 Added 95.29%
686,247 $2.11 Million
Q1 2024

May 08, 2024

SELL
$3.41 - $5.74 $19,113 - $32,172
-5,605 Reduced 1.57%
351,403 $2 Million
Q4 2023

Feb 06, 2024

BUY
$1.15 - $4.79 $69,765 - $290,590
60,666 Added 20.47%
357,008 $1.5 Million
Q3 2023

Nov 08, 2023

BUY
$1.28 - $2.41 $50,048 - $94,231
39,100 Added 15.2%
296,342 $391,000
Q2 2023

Aug 09, 2023

SELL
$1.17 - $2.03 $121,351 - $210,549
-103,719 Reduced 28.73%
257,242 $391,000
Q1 2023

May 11, 2023

BUY
$1.58 - $3.41 $570,318 - $1.23 Million
360,961 New
360,961 $631,000
Q3 2022

Nov 14, 2022

BUY
$2.95 - $4.83 $539,516 - $883,344
182,887 Added 106.11%
355,238 $1.11 Million
Q2 2022

Aug 15, 2022

SELL
$3.13 - $8.83 $52,173 - $147,187
-16,669 Reduced 8.82%
172,351 $573,000
Q1 2022

May 13, 2022

BUY
$5.87 - $9.46 $555,302 - $894,916
94,600 Added 100.19%
189,020 $1.59 Million
Q4 2021

Feb 11, 2022

BUY
$7.88 - $18.03 $744,029 - $1.7 Million
94,420 New
94,420 $775,000

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $249M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.